Higher expression of EpCAM is associated with poor clinical and pathological responses in breast cancer patients undergoing neoadjuvant chemotherapy

Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer

(2015) Rebecca L. Read et al.   ANZ JOURNAL OF SURGERY

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Curcumin Reduces Cytotoxicity of 5-Fluorouracil Treatment in Human Breast Cancer Cells

(2015) Jeannette E. Ferguson et al.   JOURNAL OF MEDICINAL FOOD

Knockdown of EpCAM Enhances the Chemosensitivity of Breast Cancer Cells to 5-fluorouracil by Downregulating the Antiapoptotic Factor Bcl-2

(2014) Jiujiao Gao et al.   PLoS One

5-fluorouracil induced cardiotoxicity: Review of the literature

(2013) Michael F. Sorrentino et al.   Cardiology Journal

Clinicopathologic Implications of EpCAM and Sox2 Expression in Breast Cancer

(2013) Nehad M.R. Abd El-Maqsoud et al.   Clinical Breast Cancer

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

CD133 Is a Useful Surrogate Marker for Predicting Chemosensitivity to Neoadjuvant Chemotherapy in Breast Cancer

(2012) Naoki Aomatsu et al.   PLoS One

EpCAM and its potential role in tumor-initiating cells

(2012) Sannia Imrich et al.   Cell Adhesion & Migration

Relationships Between Immunophenotype, Ki-67 Index, Microvascular Density, Ep-CAM/P-cadherin, and MMP-2 Expression in Early-stage Invasive Ductal Breast Cancer

(2012) Joanna A. Niemiec et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response

(2011) Carla S. Fisher et al.   ANNALS OF SURGICAL ONCOLOGY

EpCAM expression is an indicator of recurrence in basal-like breast cancer

(2011) Ayodeji J. Agboola et al.   BREAST CANCER RESEARCH AND TREATMENT

Prediction of pathologic complete response to sequential paclitaxel and 5-fluorouracil/epirubicin/cyclophosphamide therapy using a 70-gene classifier for breast cancers

(2011) Yasuto Naoi et al.   CANCER

Epithelial cell adhesion molecule expression (CD326) in cancer: A short review

(2011) Carlo Patriarca et al.   CANCER TREATMENT REVIEWS

Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer

(2011) H. Iwata et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis

(2011) Gilbert Spizzo et al.   JOURNAL OF CLINICAL PATHOLOGY

Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers

(2010) Shan Deng et al.   PLoS One

Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases

(2009) Ashley Cimino et al.   BREAST CANCER RESEARCH AND TREATMENT

Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion

(2009) N. V. Sankpal et al.   CANCER RESEARCH

The Emerging Role of EpCAM in Cancer and Stem Cell Signaling

(2009) M. Munz et al.   CANCER RESEARCH

Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers

(2009) T. Tanei et al.   CLINICAL CANCER RESEARCH

Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer

(2008) M. Schmidt et al.   CLINICAL CANCER RESEARCH